Distinct Glucose Profiles with Daily and Weekly Growth Hormone Therapy Revealed by Continuous Glucose Monitoring
The switch from somatropin to somapacitan resulted in increased interday glucose variability, characterized by biphasic glucose fluctuations, suggesting a unique physiological effect of somapacitan on glucose profiles.
Authors
- Shiki Takamura (ORCID: https://orcid.org/0000-0001-6681-0258)
- Tomomi Taguchi (ORCID: https://orcid.org/0000-0002-9000-6910)
- Akinori Hayashi (ORCID: https://orcid.org/0000-0002-9946-1004)
- Koji Takano (ORCID: https://orcid.org/0000-0002-9200-9461)
- Hideaki Shimotatara
- Takeshi Miyatsuka (ORCID: https://orcid.org/0000-0003-2618-3450)
- Ayako Hoshiyama
- Kaori Kimura
- S. Tsuji (ORCID: https://orcid.org/0000-0002-4806-6186)
- Shiori Ito
- Naoya Shimizu
- Haremaru Kubo
Institutions
- Kitasato University (JP)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1210/jendso/bvaf193
- Primary Topic
- Regulation of Appetite and Obesity
- Type
- article
- Field-Weighted Citation Impact
- 0.00